The benefits of low anterior en bloc resection as part of cytoreductive surgery for advanced primary and recurrent epithelial ovarian cancer patients outweigh morbidity concerns
- 31 December 2006
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 103 (3) , 977-984
- https://doi.org/10.1016/j.ygyno.2006.06.004
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Critical evaluation of secondary cytoreduction in recurrent ovarian cancerPublished by Elsevier ,2004
- Secondary cytoreductive surgery for patients with relapsed epithelial ovarian carcinoma: Who benefits?Cancer, 2004
- Survival Effect of Maximal Cytoreductive Surgery for Advanced Ovarian Carcinoma During the Platinum Era: A Meta-AnalysisJournal of Clinical Oncology, 2002
- Secondary Cytoreductive Surgery for Patients with Recurrent Epithelial Ovarian CarcinomaGynecologic Oncology, 2001
- The role of secondary cytoreductive surgery in the treatment of patients with recurrent epithelial ovarian carcinomaCancer, 2000
- Secondary cytoreduction for ovarian cancer following cisplatin therapy.Journal of Clinical Oncology, 1993
- The impact of subspecialty training on the management of advanced ovarian cancerGynecologic Oncology, 1992
- Radical surgical procedure improves survival time in patients with recurrent ovarian cancerCancer, 1992
- The role of partial sigmoid colectomy for debulking epithelial ovarian carcinomaGynecologic Oncology, 1991
- Cisplatin, methotrexate, and 5-fluorouracil combination chemotherapy for advanced ovarian cancerGynecologic Oncology, 1985